Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Kavanaugh

Showing results (71-80 of 381) with videos related to

Pageof 39
Sort By:
Rheumatic Diseases Clinics of North America|October 1, 2019
Treat to Target in Psoriatic ArthritisAmy D Zhang, Arthur Kavanaugh
Current Opinion in Rheumatology|April 5, 2008
Biologic therapy for early rheumatoid arthritis: the latest evidenceHernan Castro-Rueda, Arthur Kavanaugh
Current Opinion in Rheumatology|June 6, 2008
The pathobiology of psoriatic synoviumDavid L Boyle, Arthur Kavanaugh
Best Practice & Research. Clinical Rheumatology|December 8, 2014
Concepts of pathogenesis and emerging treatments for inflammatory arthritisJacob M van Laar, Arthur Kavanaugh
RMD Open|May 16, 2020
Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: A cross-sectional study of outpatient clinic patients in the biologic treatment eraGlenn Haugeberg, Brigitte Michelsen, Arthur Kavanaugh
Core Evidence|January 12, 2011
Adalimumab in ankylosing spondylitis: an evidence-based review of its place in therapyStephanie Hennigan, Christoph Ackermann, Arthur Kavanaugh
The Journal of Rheumatology|May 5, 2004
Functional status and radiographic joint damage are associated with health economic outcomes in patients with rheumatoid arthritisArthur Kavanaugh, Chenglong Han, Mohan Bala
Best Practice & Research. Clinical Rheumatology|August 14, 2003
Pharmacological treatment of established rheumatoid arthritisSusan Jung-Ah Lee, Arthur Kavanaugh
The Journal of Rheumatology|March 3, 2012
Patient assessments of skin, joint, and nail disease activity in psoriatic arthritisArthur Kavanaugh, Teresa Catalan, Sarah Cassell
The Journal of Rheumatology|June 18, 2013
Hand bone loss in patients with psoriatic arthritis: posthoc analysis of IMPACT II data comparing infliximab and placeboMari Hoff, Arthur Kavanaugh, Glenn Haugeberg
Pageof 39

Showing results (71-80 of 381) with videos related to

Sort By:
Pageof 39
Rheumatic Diseases Clinics of North America|October 1, 2019
Treat to Target in Psoriatic ArthritisAmy D Zhang, Arthur Kavanaugh
Current Opinion in Rheumatology|April 5, 2008
Biologic therapy for early rheumatoid arthritis: the latest evidenceHernan Castro-Rueda, Arthur Kavanaugh
Current Opinion in Rheumatology|June 6, 2008
The pathobiology of psoriatic synoviumDavid L Boyle, Arthur Kavanaugh
Best Practice & Research. Clinical Rheumatology|December 8, 2014
Concepts of pathogenesis and emerging treatments for inflammatory arthritisJacob M van Laar, Arthur Kavanaugh
RMD Open|May 16, 2020
Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: A cross-sectional study of outpatient clinic patients in the biologic treatment eraGlenn Haugeberg, Brigitte Michelsen, Arthur Kavanaugh
Core Evidence|January 12, 2011
Adalimumab in ankylosing spondylitis: an evidence-based review of its place in therapyStephanie Hennigan, Christoph Ackermann, Arthur Kavanaugh
The Journal of Rheumatology|May 5, 2004
Functional status and radiographic joint damage are associated with health economic outcomes in patients with rheumatoid arthritisArthur Kavanaugh, Chenglong Han, Mohan Bala
Best Practice & Research. Clinical Rheumatology|August 14, 2003
Pharmacological treatment of established rheumatoid arthritisSusan Jung-Ah Lee, Arthur Kavanaugh
The Journal of Rheumatology|March 3, 2012
Patient assessments of skin, joint, and nail disease activity in psoriatic arthritisArthur Kavanaugh, Teresa Catalan, Sarah Cassell
The Journal of Rheumatology|June 18, 2013
Hand bone loss in patients with psoriatic arthritis: posthoc analysis of IMPACT II data comparing infliximab and placeboMari Hoff, Arthur Kavanaugh, Glenn Haugeberg
Pageof 39